Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news
Hepatitis C drug cost-effective for anemia
LOS ANGELES, Oct 3, 2005 (UPI via COMTEX) -- University of Los Angeles research suggests a Hepatitis C drug is cost-effective in helping patients with treatment-induced anemia.
The study -- conducted with the Veterans Affairs Greater Los Angeles Healthcare System -- found that for Hepatitis C patients who develop treatment-induced anemia due to a key medication, it is more cost-effective to take an additional drug to help prevent anemia, rather than reducing or stopping treatment altogether, which has been the standard approach.
Researchers said the study may lead to a new treatment standard for the one-third of Hepatitis C patients who develop treatment-induced anemia as a result of taking ribarvirin.
More than 4 million Americans are infected with Hepatitis C.
The research is detailed in the current edition of the journal Clinical Gastroenterology and Hepatology.
URL: www.upi.com